twoXAR is an artificial intelligence-driven biopharmaceutical company. The company leverages its computational platform to identify promising drug candidates, de-risks the opportunities through preclinical studies, and progresses drug candidates to the clinic through industry partnerships. Based in Palo Alto, California, the twoXAR team includes experts in drug discovery and development, biomedical informatics, computational biology, data science and software development.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 03/19/18 | $10,000,000 | Series A |
OS Fund SoftBank Ventures  | undisclosed |
